MD/PhD Program in Medicine, the Social Sciences and Alzheimer's Disease and Related Dementias

医学、社会科学和阿尔茨海默病及相关痴呆症医学博士/博士项目

基本信息

  • 批准号:
    10340783
  • 负责人:
  • 金额:
    $ 22.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-30 至 2026-09-29
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT This proposal seeks support for an MD/PhD Program in Medicine, the Social Sciences, and Alzheimer’s Disease and Related Dementias (AD/ADRD) centered at the University of Chicago (UC) in partnership with Rush University (RU). The program builds on strengths at the two institutions in Alzheimer’s disease and related dementias (AD/ADRD), the social sciences, and interdisciplinary research and its integration into the professions, including the training of MD/PhD students with PhDs in the Social Sciences. The proposed program will produce MD/PhD graduates trained in medicine, a social science or related profession (Economics, Sociology, Psychology, Comparative Human Development, Public Health Sciences, Business, Public Policy, and Social Work), and interdisciplinary approaches to aging research with a focus on AD/ADRD. AD/ADRD research training areas will include the epidemiology of AD/ADRD; the content, organization, and financing of care for persons with dementia; behavioral, health system and community interventions aimed at the prevention, early identification, and treatment of AD/ADRD; the care workforce and roles of formal and informal caregivers in health outcomes for persons with AD/ADRD; and methodological issues prominent in AD/ADRD research. The proposed approach to training builds on UC’s 30-year history of national leadership in training MD/PhDs in the social sciences through the Medicine, Social Sciences and Humanities (MeSH) program. UC’s training record has been exceptional, training more MD/PhDs in the social sciences than any other institution with exceptional placement and scientific impact in aging and AD/ADRD research. MD/PhD applicants will be able to apply to the program through one of three tracks: 1) the Pritzker School of Medicine Track, in which students apply simultaneously to the MD and PhD programs at UC; 2) the Rush Medical College (RMC) Track, in which students apply simultaneously to the MD program at RMC and PhD programs at UC; 3) the National Track, in which students at any U.S. medical school may apply to PhD programs at UChicago. The proposed program also benefits from the exceptional clinical and research expertise at RU in AD/ADRD, and RU’s participation expands local medical school options for trainees interested in research careers in AD/ADRD and earning a social science PhD from UC. The National Track pathway will also continue to further expand the pool of potential candidates eligible for the program by recruiting students from across the U.S., which we expect to especially help in expanding recruitment of minority trainees. Institutional support will allow us to matriculate 3 PSOM or RMC track students and at least 3 National Track students over the course of the award. Trainees’ focus on AD/ADRD research will be enhanced by their participation in relevant coursework, clinical experiences, and seminars in which they present their work to their colleagues and program leaders.Each trainee will be supervised by an interdisciplinary mentorship team including at least 1 MD/PhD in the Social Sciences, 1 NIA-funded AD/ADRD researcher, and 1 practicing geriatrician.
项目摘要/摘要 该建议寻求支持医学,社会科学和阿尔茨海默氏症的MD/博士学位计划 疾病及相关痴呆症(AD/ADRD)以芝加哥大学(UC)为中心 拉什大学(RU)。该计划以阿尔茨海默氏病和 相关痴呆症(AD/ADRD),社会科学和跨学科研究及其融入 专业,包括在社会科学中对拥有博士学位的医学博士/博士学位培训。提议 计划将生产接受医学培训,社会科学或相关职业的MD/PHD毕业生 (经济学,社会学,心理学,比较人类发展,公共卫生科学,商业, 公共政策和社会工作)以及跨学科研究的方法,重点是广告/ADRD。 AD/ADRD研究培训领域将包括AD/ADRD的流行病学;内容,组织和 为痴呆症患者提供护理筹集;针对的行为,卫生系统和社区干预措施 AD/ADRD的预防,早期识别和治疗;护理员工和正式的角色和 广告/ADRD患者的健康成果的非正式护理人员;以及方法论问题在 广告/ADRD研究。拟议的培训方法是基于加州大学(UC)30年的国家领导历史 通过医学,社会科学和人文科学(网格)在社会科学中培训MD/PHD 程序。 UC的培训记录非常出色,社会科学中的MD/PHD培训比任何人都多 其他机构在衰老和AD/ADRD研究中具有出色的位置和科学影响。 MD/PHD 申请人将能够通过三个曲目之一申请该计划:1)Pritzker医学院 轨道,学生仅申请UC的MD和博士学位课程; 2)Rush Medical 大学(RMC)曲目,其中学生仅申请RMC和PhD计划的MD计划 在UC; 3)国家轨道,其中任何美国医学院的学生都可以申请 乌奇加哥。拟议的计划还受益于Ru In的卓越临床和研究专业知识 AD/ADRD和RU的参与扩大了当地医学院的选择,以获取研究有趣的培训 AD/ADRD的职业和从UC获得社会科学博士学位。国家轨道途径也将继续 通过招募来自各地的学生,进一步扩大了有资格获得该计划的潜在候选人的库 美国,我们期望特别有助于扩大少数群体学员的招聘。机构支持 将允许我们矩阵3 PSOM或RMC跟踪学生以及至少3个国家田径学生 奖项课程。受训者对广告/ADRD研究的关注将通过参与相关的研究来增强 课程工作,临床经验和半小伙子,他们向同事和 计划负责人。每个学员将受到跨学科心态团队的监督,包括至少1个 社会科学中的MD/PHD,1名NIA资助的AD/ADRD研究员和1位实践老年医生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID O MELTZER其他文献

DAVID O MELTZER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID O MELTZER', 18)}}的其他基金

Defragmenting Care for Patients at Increased Risk of Hospitalization: A Conference on Comprehensive Care
对住院风险增加的患者进行整理护理:综合护理会议
  • 批准号:
    10673492
  • 财政年份:
    2023
  • 资助金额:
    $ 22.02万
  • 项目类别:
MD/PhD Program in Medicine, the Social Sciences and Alzheimer's Disease and Related Dementias
医学、社会科学和阿尔茨海默病及相关痴呆症医学博士/博士项目
  • 批准号:
    10687248
  • 财政年份:
    2021
  • 资助金额:
    $ 22.02万
  • 项目类别:
MD/PhD Program in Medicine, the Social Sciences and Alzheimer's Disease and Related Dementias
医学、社会科学和阿尔茨海默病及相关痴呆症医学博士/博士项目
  • 批准号:
    10493382
  • 财政年份:
    2021
  • 资助金额:
    $ 22.02万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10215380
  • 财政年份:
    2020
  • 资助金额:
    $ 22.02万
  • 项目类别:
Center for Health Aging Behaviors and Longitudinal InvestigationS (CHABLIS)
健康老龄化行为和纵向调查中心 (CHABLIS)
  • 批准号:
    10663322
  • 财政年份:
    2020
  • 资助金额:
    $ 22.02万
  • 项目类别:
Center for Healthy Aging Behaviors & Longitudinal InvestigationS (CHABLIS): Diversity Supplement 3
健康老龄行为中心
  • 批准号:
    10799365
  • 财政年份:
    2020
  • 资助金额:
    $ 22.02万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10435513
  • 财政年份:
    2020
  • 资助金额:
    $ 22.02万
  • 项目类别:
Innovative Network
创新网络
  • 批准号:
    10663329
  • 财政年份:
    2020
  • 资助金额:
    $ 22.02万
  • 项目类别:
Center for Healthy Aging Behaviors & Longitudinal InvestigationS (CHABLIS): Diversity Supplement 4
健康老龄行为中心
  • 批准号:
    10799417
  • 财政年份:
    2020
  • 资助金额:
    $ 22.02万
  • 项目类别:
Center for Healthy Aging Behaviors & Longitudinal InvestigationS (CHABLIS): Diversity Supplement 1
健康老龄行为中心
  • 批准号:
    10799426
  • 财政年份:
    2020
  • 资助金额:
    $ 22.02万
  • 项目类别:

相似海外基金

Developing a nonpharmacological pain intervention for community dwelling older adults with dementia
为社区居住的痴呆症老年人开发非药物疼痛干预措施
  • 批准号:
    10644490
  • 财政年份:
    2023
  • 资助金额:
    $ 22.02万
  • 项目类别:
Preparing for Blood-Based Alzheimer’s Disease Biomarker Testing in Diverse Populations: Development of a Decision-Support Tool for Primary Care
为不同人群进行基于血液的阿尔茨海默病生物标志物测试做好准备:开发初级保健决策支持工具
  • 批准号:
    10722716
  • 财政年份:
    2023
  • 资助金额:
    $ 22.02万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10729952
  • 财政年份:
    2023
  • 资助金额:
    $ 22.02万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10730060
  • 财政年份:
    2023
  • 资助金额:
    $ 22.02万
  • 项目类别:
Analytical Core
分析核心
  • 批准号:
    10730061
  • 财政年份:
    2023
  • 资助金额:
    $ 22.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了